XML 131 R115.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings per share - Summary of earnings per share (Detail) - AUD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Earnings per share [abstract]      
Loss after income tax attributable to the owners of Kazia Therapeutics Limited $ (20,465,180) $ (25,014,055) $ (8,420,000)
Loss after income tax attributable to the owners of Kazia Therapeutics Limited $ (20,465,000) $ (25,014,000) $ (8,420,000)
Weighted average number of ordinary shares used in calculating basic earnings per share 184,284,350 132,467,686 117,674,543
Weighted average number of ordinary shares used in calculating diluted earnings per share 184,284,350 132,467,686 117,674,543
Basic earnings per share $ (0.1123) $ (0.1888) $ (0.0716)
Diluted earnings per share $ (0.1123) $ (0.1888) $ (0.0716)